WA
TXG icon

WPG Advisers’s 10x Genomics TXG Stock Holding History

WPG Advisers’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230 Hold
6
– – ﹤0.01% 1496
2026
Q1 		$127 Hold
6
– – ﹤0.01% 1446
2025
Q4 		$98 Hold
6
– – ﹤0.01% 1463
2025
Q3 		$70 Hold
6
– – ﹤0.01% 1439
2025
Q2 		$69 Hold
6
– – ﹤0.01% 1423
2025
Q1 		$52 Sell
6
-11
-65% -$139 ﹤0.01% 1424
2024
Q4 		$244 Buy
+17
New +$268 ﹤0.01% 1421

Other funds holding TXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

WPG Advisers's TXG Position: Q2 2026 in Review

WPG Advisers held its 10x Genomics (TXG) position steady in Q2 2026 at 6 shares worth $230. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

WPG Advisers first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $244 in Q4 2024. 157 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • WPG Advisers held 6 shares of 10x Genomics worth $230 as of Q2 2026.
  • WPG Advisers left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1496 holding.
  • WPG Advisers first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's 10x Genomics position peaked at $244 in Q4 2024.
  • 157 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.